Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.05%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
304.51 Up 2.35(0.78%) 3:59PM EDT
|After Hours : 315.75 Up 11.24 (3.69%) 7:59PM EDT
Company EventsGet Company Events for:
Upcoming Events 
DateEventReminder
5-Aug-14Earnings announcementSet a Reminder
Recent Events 
DateEvent
21-Jul-14Coverage initiated on Regeneron Pharms by Argus
18-Jun-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
23-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K/A, Unregistered Sale of Equity Securities
19-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
8-May-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
9-Apr-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
31-Mar-14Sanofi SA and Regeneron Pharmaceuticals Inc IR Thematic Conference Call on Alirocumab scheduled for 9:00 am ET today
5-Mar-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
13-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
11-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
5-Feb-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
16-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
14-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
13-Jan-14REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
5-Nov-13REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
3-Oct-13REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
12-Sep-13REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
6-Aug-13REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financ